Profiel
A. Grant Heidrich is currently a Director at Octave Bioscience, Inc. He was previously a Director at Millennium Pharmaceuticals, Inc., Cytokinetics, Inc., AVEO Pharmaceuticals, Inc., Tularik, Inc., National Venture Capital Association, Mayfield Fund LLC, Western Association of Venture Capitalists, and a Strategic Advisor at The Column Group LLC.
He holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Stanford University.
Actieve functies van A. Grant Heidrich
| Bedrijven | Functie | Begin |
|---|---|---|
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Directeur/Bestuurslid | - |
Eerdere bekende functies van A. Grant Heidrich
| Bedrijven | Functie | Einde |
|---|---|---|
Mayfield Fund LLC
Mayfield Fund LLC Investment ManagersFinance Mayfield Fund invests in companies located in the United States. The firm focuses on AI, enterprise, consumer, semiconductor, and human & planetary health sectors. It provides financing for early and later stage capital requirements. | Directeur/Bestuurslid | 11-01-2011 |
| CYTOKINETICS, INCORPORATED | Directeur/Bestuurslid | 09-02-2011 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur/Bestuurslid | 14-05-2008 |
| AVEO PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-04-2007 |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Corporate Officer/Principal | - |
Opleiding van A. Grant Heidrich
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Mayfield Fund LLC
Mayfield Fund LLC Investment ManagersFinance Mayfield Fund invests in companies located in the United States. The firm focuses on AI, enterprise, consumer, semiconductor, and human & planetary health sectors. It provides financing for early and later stage capital requirements. | Finance |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Western Association of Venture Capitalists
Western Association of Venture Capitalists Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit trade association that provides services | Commercial Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Health Technology |
















